Please assess the completion status of the following clinical trial:

Trial Title: PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* written informed consent~* 18 years ≤ age ≤ 35 years on the day of the first visit~* 22.0 ≤ BMI ≤ 28.0 kg/m2~* (History of) good physical and mental health as determined by history taking, physical and laboratory examinations and ECG.~* fasting glucose level of \< 5.6 mmol/L, in addition to a glucose level of \< 7.8 mmol/L at 2 hours after intake of 75 g glucose (OGTT).~* able to keep a normal day and night rhythm during the trial period (i.e. no shift work)~Exclusion Criteria:~* history or presence of a medical disorder~* use of drugs, except for incidental (non-opioid) analgesic agents~* first degree relative with T2DM~* performing intensive physical activity \> 1x/week~* an allergic or anaphylactic reaction to prednisolone treatment in the past~* clinically relevant history or presence of any medical disorder, which are mentioned in the Summary of Product Characteristics (SPC) as contraindication for the use of prednisolone~* glucocorticosteroid use during the last three months prior to the first dose~* participation in an investigational drug trial within 90 days prior to the first dose~* donation of blood (\> 100 mL) within 90 days prior to the first dose~* history of or current abuse of drugs or alcohol (\>14 U/week)~* smoking~* use of grapefruit products during the study period~* recent changes in weight and/or physical activity~* serious mental impairment or language problems i.e. preventing to understand the study protocol/aim

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): None
- 2 (Type: ACTIVE_COMPARATOR): None
- 3 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).